Eltrombopag: a review of its use in patients with severe aplastic anaemia.
about
Lusutrombopag: First Global Approval.Eltrombopag: A Review in Paediatric Chronic Immune Thrombocytopenia.Revealing eltrombopag's promotion of human megakaryopoiesis through AKT/ERK-dependent pathway activationInnovation in the field of thrombocytopenias: achievements since the beginning of the century and promises for the future.
P2860
Eltrombopag: a review of its use in patients with severe aplastic anaemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Eltrombopag: a review of its use in patients with severe aplastic anaemia.
@en
type
label
Eltrombopag: a review of its use in patients with severe aplastic anaemia.
@en
prefLabel
Eltrombopag: a review of its use in patients with severe aplastic anaemia.
@en
P2860
P1433
P1476
Eltrombopag: a review of its use in patients with severe aplastic anaemia.
@en
P2093
Paul L McCormack
P2860
P2888
P304
P356
10.1007/S40265-015-0363-4
P577
2015-04-01T00:00:00Z
P5875
P6179
1018053510